This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jeff Paul: Innovator in Pharmaceutical Dosage Forms
Introduction
Jeff Paul is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel dosage forms. His work focuses on improving treatment methods for various diseases and disorders.
Latest Patents
Jeff Paul holds a patent for "Bifeprunox mesylate maintenance dose compositions and methods for using the same." This patent provides innovative pharmaceutical dosage forms, including maintenance treatment doses, and outlines methods for creating and utilizing these compounds to treat and prevent diseases and disorders.
Career Highlights
Jeff Paul is associated with Solvay Pharmaceuticals B.V., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing treatment options in the medical field.
Collaborations
Throughout his career, Jeff has collaborated with notable colleagues, including Irene Eijgendaal and Gerrit Klein. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Jeff Paul's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective treatment methods. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile